Karen Reeves
Corporate Officer/Principal bij LIGAND PHARMACEUTICALS INCORPORATED
Actieve functies van Karen Reeves
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 20-02-2024 | - |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Hoofd Techniek/Wetenschap/O&O | 01-09-2017 | - |
| President | 01-09-2017 | - |
Loopbaan van Karen Reeves
Eerdere bekende functies van Karen Reeves
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KIROMIC BIOPHARMA, INC. | Directeur/Bestuurslid | 14-02-2022 | 06-12-2022 |
| Independent Dir/Board Member | 14-02-2022 | 06-12-2022 | |
| MEDIVATION INC | Corporate Officer/Principal | 18-12-2009 | 29-03-2010 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Opleiding van Karen Reeves
| Yale University | Undergraduate Degree |
| University of Vermont College of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Japan | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| KIROMIC BIOPHARMA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ASTELLAS PHARMA INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Karen Reeves
- Ervaring
